NCT00419445View on ClinicalTrials.gov

Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

GTS21/Placebo

Trial Locations (2)

Unknown

George Washington University Medical Center, Washington D.C.

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

CoMentis

INDUSTRY